Post

Merck plans €300m investment at new German research centre

Merck KGaA (Merck) has announced an investment of more than €300m ($320.8m) in a new Life Science Research Center at …

Mundipharma to acquire rezafungin assets from Cidara Therapeutics

Mundipharma has signed an agreement to acquire all assets and rights related to antifungal candidate Rezzayo (rezafungin) from Cidara Therapeutics, …

Life science SMEs “heading out of the funding winter”

After what has been deemed a “funding winter” for life science SMEs, building a strong data package to attract larger …

Biogen reports net income of $393.4m in Q1 2024

Biogen has reported net income of $393.4m for the first quarter (Q1) of 2024, an increase from $387.6m in the …

FDA approves Utility Therapeutics’ Pivya tablets for UTIs

The US Food and Drug Administration (FDA) has approved Utility Therapeutics’ Pivya tablets, a new treatment for female adults with …